학술논문

Event‐based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross‐sectional data
Document Type
article
Author
Lopez, Seymour MAksman, Leon MOxtoby, Neil PVos, Sjoerd BRao, JunKaestner, ErikAlhusaini, SaudAlvim, MarinaBender, BenjaminBernasconi, AndreaBernasconi, NedaBernhardt, BorisBonilha, LeonardoCaciagli, LorenzoCaldairou, BenoitCaligiuri, Maria EugeniaCalvet, AngelsCendes, FernandoConcha, LuisConde‐Blanco, EstefaniaDavoodi‐Bojd, Esmaeilde Bézenac, ChristopheDelanty, NormanDesmond, Patricia MDevinsky, OrrinDomin, MartinDuncan, John SFocke, Niels KFoley, SonyaFortunato, FrancescoGalovic, MarianGambardella, AntonioGleichgerrcht, EzequielGuerrini, RenzoHamandi, KhalidIves‐Deliperi, VictoriaJackson, Graeme DJahanshad, NedaKeller, Simon SKochunov, PeterKotikalapudi, RavitejaKreilkamp, Barbara AKLabate, AngeloLarivière, SaraLenge, MatteoLui, ElaineMalpas, CharlesMartin, PascalMascalchi, MarioMedland, Sarah EMeletti, StefanoMorita‐Sherman, Marcia EOwen, Thomas WRichardson, MarkRiva, AntonellaRüber, TheodorSinclair, BenSoltanian‐Zadeh, HamidStein, Dan JStriano, PasqualeTaylor, Peter NThomopoulos, Sophia IThompson, Paul MTondelli, ManuelaVaudano, Anna ElisabettaVivash, LucyWang, YujiangWeber, BerndWhelan, Christopher DWiest, RolandWinston, Gavin PYasuda, Clarissa LinMcDonald, Carrie RAlexander, Daniel CSisodiya, Sanjay MAltmann, AndreBargalló, NúriaBartolini, EmanueleO’Brien, Terence JThomas, Rhys H
Source
Epilepsia. 63(8)
Subject
Brain Disorders
Epilepsy
Neurodegenerative
Neurosciences
Clinical Research
Biomedical Imaging
Aetiology
2.1 Biological and endogenous factors
Neurological
Good Health and Well Being
Atrophy
Biomarkers
Cross-Sectional Studies
Epilepsy
Temporal Lobe
Hippocampus
Humans
Magnetic Resonance Imaging
Sclerosis
disease progression
duration of illness
event-based model
MTLE
patient staging
ENIGMA-Epilepsy Working Group
Clinical Sciences
Neurology & Neurosurgery
Language
Abstract
ObjectiveRecent work has shown that people with common epilepsies have characteristic patterns of cortical thinning, and that these changes may be progressive over time. Leveraging a large multicenter cross-sectional cohort, we investigated whether regional morphometric changes occur in a sequential manner, and whether these changes in people with mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE-HS) correlate with clinical features.MethodsWe extracted regional measures of cortical thickness, surface area, and subcortical brain volumes from T1-weighted (T1W) magnetic resonance imaging (MRI) scans collected by the ENIGMA-Epilepsy consortium, comprising 804 people with MTLE-HS and 1625 healthy controls from 25 centers. Features with a moderate case-control effect size (Cohen d ≥ .5) were used to train an event-based model (EBM), which estimates a sequence of disease-specific biomarker changes from cross-sectional data and assigns a biomarker-based fine-grained disease stage to individual patients. We tested for associations between EBM disease stage and duration of epilepsy, age at onset, and antiseizure medicine (ASM) resistance.ResultsIn MTLE-HS, decrease in ipsilateral hippocampal volume along with increased asymmetry in hippocampal volume was followed by reduced thickness in neocortical regions, reduction in ipsilateral thalamus volume, and finally, increase in ipsilateral lateral ventricle volume. EBM stage was correlated with duration of illness (Spearman ρ = .293, p = 7.03 × 10-16 ), age at onset (ρ = -.18, p = 9.82 × 10-7 ), and ASM resistance (area under the curve = .59, p = .043, Mann-Whitney U test). However, associations were driven by cases assigned to EBM Stage 0, which represents MTLE-HS with mild or nondetectable abnormality on T1W MRI.SignificanceFrom cross-sectional MRI, we reconstructed a disease progression model that highlights a sequence of MRI changes that aligns with previous longitudinal studies. This model could be used to stage MTLE-HS subjects in other cohorts and help establish connections between imaging-based progression staging and clinical features.